FDA: Accelerated approval for Genmab and Seagen’s TIVDAK
September 21, 2021Manufacturing and Production, Research and Development
The FDA has granted accelerated approval for Genmab and Seagen’s TIVDAK (tisotumab vedotin-tftv), the first and only approved antibody-drug conjugate …
AstraZeneca to invest $340 million on Irish site
September 21, 2021Manufacturing and Production
AstraZeneca has announced on Tuesday a $340 million plan to establish an active pharmaceutical ingredient (API) manufacturing facility for small …
Vectura removed from DDL Conference amid PMI deal
September 21, 2021Manufacturing and Production DDL, inhalers, pmi, vectura
Inhaler and medical device maker Vectura has been removed from pharma conferences Formulation and Delivery UK and Drug Delivery to …
AstraZeneca, Klarify, and Novartis Gene Therapies top Digital Awards leaderboard
September 20, 2021Sales and Marketing AstraZeneca, Klarify, Novartis, PM Society Awards, havas life medicom
Pharmaceutical companies AstraZeneca, Klarify, and Novartis Gene Therapies all received two gold awards at the 12th PM Society Digital Awards …
Singapore scientists turn discarded fruit peel into antibacterial bandages
September 20, 2021Research and Development, Sales and Marketing
Scientists at Nanyang Technological University (NTU) in Singapore have created antibacterial organo-hydrogel bandages from discarded durian peel.The process extracts cellulose …
Cambodian bat researchers aiming to find COVID-19 origin
September 20, 2021Research and Development, Sales and Marketing
An eight-member Institut Pasteur du Cambodge (IPC) research team has been collecting samples from bats in an attempt to discover …
ONS data shows long COVID less common than feared
September 17, 2021Medical Communications
New data released by the Office for National Statistics (ONS) reveal that only one in 40 people with coronavirus goes …
NICE recommends MSD’s Keytruda for oesophageal cancer patients
September 17, 2021Medical Communications, Research and Development
NICE has approved the use of pembrolizumab – MSD’s checkpoint inhibitor immunotherapy – in combination with platinum- and fluoropyrimidine-based chemotherapy, …
Health Canada announce first full approval for Moderna COVID-19 vaccine
September 17, 2021Medical Communications AstraZeneca, BioNTech, Health Canada, Moderna, Pfizer, mrna
Canada has become the first country in the world to grant full approval to the Moderna vaccine, alongside confirmation for …
Moderna and Pfizer COVID-19 vaccine protection declines over time
September 16, 2021Business Services COVID-19, FDA, Moderna, Pfizer, comirnaty
Data presented by Pfizer and Moderna ahead of the FDA’s vaccine advisory committee meeting on Friday suggest that protection from …
Researchers develop AI algorithm to diagnose deep vein thrombosis
September 16, 2021Medical Communications, Research and Development
Researchers from the University of Oxford, Imperial College, and the University of Sheffield have developed a machine learning algorithm with …
Menstrual changes after COVID jab must be investigated, says leading immunologist
September 16, 2021Medical Communications
Changes to periods and unexpected vaginal bleeding has been reported by 30,000 women to UK regulators, and now leading immunologist …
Sanofi complete acquisition of mRNA company Translate Bio
September 15, 2021Research and Development 2021, 3.2 billion, COVID-19, Sanofi, Translate Bio, acquisition, mrna, vaccines
French pharma giants Sanofi continues its run of acquisitions in 2021 by completing the deal for Translate Bio, a Massachusetts-based …
COVID deaths among fully vaccinated rare, ONS data finds
September 15, 2021Medical Communications, Research and Development
New figures from the Office for National Statistics (ONS) show that fully vaccinated people are far less likely to die …
Sajid Javid: Valneva COVID vaccine would not have been approved by MHRA
September 15, 2021Manufacturing and Production, Medical Communications, Research and Development
On Monday the UK cancelled a deal with French vaccine maker Valneva worth up to €1.4 billion, and Health Secretary …
NHS in Scotland makes rheumatoid arthritis drug available
September 14, 2021Manufacturing and Production Galapagos UK, NHS, Scotland, filgotinib, rheumatoid arthritis
The Scottish Medicines Consortium (SMC) have recommended the use of Galapagos UK’s JYSELECA® (filgotinib) for eligible patients with severe active …
Israeli survey finds 1 in 10 children have long COVID
September 14, 2021Medical Communications, Research and Development
An Israeli Health Ministry survey has found that one in ten children have lingering COVID-19 symptoms after contracting and recovering …
J&J publish promising Ebola vaccine data
September 14, 2021Research and Development
Johnson & Johnson have released promising data regarding their Ebola vaccine regimen, as it demonstrates antibody immune responses in adults …
NHS launches new blood test to detect over 50 types of cancer early
September 13, 2021Sales and Marketing
A world-first trial of a new cancer test began today as the NHS launched its Galleri trial, which seeks to …
BioNTech seek approval for COVID-19 vaccine in children aged 5-11
September 13, 2021Sales and Marketing COVID-19, FDA, Vaccine, children
Children between 5 and 11 years old are to be targeted by BioNTech as the company seeks approval for younger …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
